How to Buy Casi Pharmaceuticals Stock
Casi Pharmaceuticals Inc
CASI Pharmaceuticals, Inc. , a biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in China, the United States, and internationally.
Casi Pharmaceuticals stock last closed at $2.30, down 5.74% from the previous day, and has decreased 22.56% in one year. It has overperformed other stocks in the Biotechnology industry by 0.01 percentage points. Casi Pharmaceuticals stock is currently +24.32% from its 52-week low of $1.85, and -72.88% from its 52-week high of $8.48.
There are currently 13.38M CASI shares outstanding. The market cap of CASI is $30.77M. In the last 24 hours, 27,748 CASI shares were traded.
How to Buy Casi Pharmaceuticals Stock
Wondering how to invest in Casi Pharmaceuticals stock? Here's how.
- Figure out where to buy Casi Pharmaceuticals stock: You need to decide on an online brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Casi Pharmaceuticals stock.
- Create a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Deposit money your brokerage account: Pick your method of payment and add your details.
- Evaluate Casi Pharmaceuticals stock: The Casi Pharmaceuticals ticker symbol is CASI. Is Casi Pharmaceuticals stock a good investment? Should you buy shares of CASI? How do CASI's underlying business fundamentals look? Do top analysts think Casi Pharmaceuticals is a good buy? Why has CASI's stock price moved recently? (Hint: Our stock market research tools can help you decide if CASI is a good stock to buy).
- Place your CASI buy order: Decide if you will purchase CASI shares at the current market price or use a limit order to buy CASI stock at a particular price.
- Get notifications regarding your CASI position: Create a watchlist to key updates about your new investment in Casi Pharmaceuticals stock.
Step 1: Figure out where to buy Casi Pharmaceuticals stock
You need an online brokerage account to access the NASDAQ market and buy CASI stock.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Utilities, New York to Shanghai — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by signing up for an account with eToro today.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen the right brokerage, the next step is to fill out some personal info so you are able to buy CASI stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to start your new trading account.
- Submit your information by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have created your account on our top ranked stock market app, you need to deposit funds:
Check out this video walkthrough if you need help depositing money into your investment account.
Step 4: Evaluate Casi Pharmaceuticals stock
Once you have chosen the best place to buy Casi Pharmaceuticals stock, it's very important to research their stock prior to buying, so you truly wrap your head around the risk as well as the upside.
Overview of key CASI info
Casi Pharmaceuticals Due Diligence Checks
WallStreetZen was created to help part-time investors perform better fundamental analysis in less time.
You can view all of the due diligence checks on CASI's stock page.
What is the fair value of CASI stock?
Analysts use many financial metrics, analyses, models, and charts to gauge CASI's fair value.
Using relative valuations measures:
- CASI could be undervalued based on its P/B ratio of 1.27x, relative to Biotechnology industry P/B ratio of 5.8x
You can access more valuation research on CASI's stock here.
How do CASI Financials look?
Signs that CASI is financially healthy:
- CASI has cash burn of 22208000. It has enough cash and short-term investments to cover this for at least one year.
- CASI has $30.77M in cash and short term investments. This is sufficient to cover its annual cash burn of $22.21M.
- There are more short-term assets than short-term liabilities on the CASI balance sheet.
- There are more short-term assets than long-term liabilities on the CASI balance sheet.
Signs that CASI is not financially healthy:
- CASI has a relatively high debt to equity ratio of 2.12.
- Total CASI debt is higher than 5 years ago, relative to shareholder equity.
- CASI profit margin has gone up by 0.15 percentage points in the past year, but the company is still unprofitable.
Is Casi Pharmaceuticals stock a Buy, Hold, or Sell, according to analysts?
Out of 1 Equities analysts who give recommendations on CASI, the consensus analyst rating on Casi Pharmaceuticals is a Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
You can dive deeper into what analysts are forecasting on the Casi Pharmaceuticals stock forecast page.
Metrics for Advanced CASI Traders
How is CASI performing as a company?
Last year, CASI revenue was $33.88M. In the last four year, CASI's revenue has grown by 69.23% per year. This was faster than the Biotechnology industry average of 28.62%.
You can research CASI's earnings and revenue performance here.
What are CASI insiders up to?
Over the last 12 months, insiders at CASI have not bought or sold any shares.
Get more info about who owns CASI stock here.
Can I get consistent income from CASI stock?
No, Casi Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get opinions from other investors
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Place your CASI buy order
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and eToro will execute the order.
If you need more help buying stocks on eToro, watch the helpful video below:
Step 6: Get notifications regarding your CASI position
Now that you own some shares in CASI, you'll want to keep up with your investment.
Add CASI to a watchlist to get alerted to the latest events about your CASI stock.
CASI Feed
How to Buy Stock in Casi Pharmaceuticals
To reiterate, here are the 6 steps to buy Casi Pharmaceuticals stock:
- Figure out where to buy Casi Pharmaceuticals stock
- Create a brokerage account
- Deposit money your brokerage account
- Evaluate Casi Pharmaceuticals stock
- Place your CASI buy order
- Get notifications regarding your CASI position
If you need a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to monitor your investment in Casi Pharmaceuticals, hit the button below to create your watchlist.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.